Dose-Ranging Efficacy and Safety Study of Topical Rapamycin Cream for Facial Angiofibroma Associated With Tuberous Sclerosis Complex

NCT03826628 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

107

Enrollment

INDUSTRY

Sponsor class

Conditions

Facial Angiofibroma
Tuberous Sclerosis

Interventions

DRUG: rapamycin
DRUG: placebo

Sponsor

Dermatology Specialties Limited Partnership